Pharmaceuticals, Biotechnology and Life Sciences
Hemostemix has received all approvals from two new medical centers to be clinical trial sites for its Phase II clinical trial for critical limb ischemia (CLI), the company said in an update on the patient enrolment.
ProQR Therapeutics N.V. got Fast Track designation from the Food and Drug Administration (FDA) for QR-421a, a first-in-class investigational RNA-based oligonucleotide to tackle the underlying cause of the vision loss related to the Usher syndrome type 2 and non-syndromic retinitis pigmentosa (RP) due to mutations in exon 13 of the USH2A gene.
Geron Corporation on Monday said that its Chairman of the board Dr. Hoyoung Huh has resigned from the Board, his roles as Chairman of the Board and as a member of the Nominating and Corporate Governance Committee, noting personal reasons.
ATAI Life Sciences AG has acquired a majority stake in New York based Perception Neuroscience, a biopharmaceutical company focused on developing innovative therapies in neuropsychiatry.
CTI BioPharma has enrolled 150 patients with myelofibrosis previously treated with ruxolitinibto be tested on pacritinib in the second phase, testing three dosing schedules over 24 weeks.
A vaccine made by joint effort of Merck and Sanofi Pasteur, the vaccines unit of Sanofi, Vaxelis – for children younger than 5 – got the US FDA’s approval for six active immunization indications.
The Israeli Parliament, the Knesset, on December 25th, passed a bill that concerns the governance and regulatory aspects of exporting medical cannabis from Israel, said on Wednesday a manufacturer of automated commercial growing devices for medical grade cannabis, Seedo Corp.
Myriad Genetics’ study results on development of the adjusted Vectra, announced Wednesday, found it outperforming typical measures of disease activity in predicting new joint damage in rheumatoid arthritis patients.
A China-based clinical stage biopharmaceutical immuno-oncology and autoimmune diseases focused company, I-Mab Biopharma (I-Mab), said Monday it got the US Food and Drug Administration (FDA) has approval for its IND application for TJM2, a potential treatment for autoimmune and inflammatory diseases.
PledPharma has filed an application for an Orphan Drug Designation (ODD) to the US FDA for the its drug candidate which should reduce liver injury by paracetamol overdose, Aladote.